{"filing":{"accession_number":"0001828316-26-000047","cik":"0001828316","ticker":"PHAR","company_name":"Pharming Group N.V.","form":"6-K","filing_date":"2026-10-22","report_date":"2026-10-22","primary_document":"q3announcementpr.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1828316/000182831626000047/q3announcementpr.htm"},"events":[{"id":37025,"run_id":34126,"accession_number":"0001828316-26-000047","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a press release announcing preliminary third-quarter 2026 financial results for Pharming Group N.V., disclosing total revenues of approximately US$117.6 million (21% year-over-year growth) and operating expenses of US$74.6 million, along with tightened full-year 2026 revenue guidance. The disclosure explicitly states \"Pharming Group announces third quarter 2026 revenues above market expectations\" and provides preliminary unaudited revenue and select financial information for the three months ended September 30, 2026, which is the hallmark of an earnings release.","company_name":"Pharming Group N.V.","ticker":"PHAR","filing_date":"2026-10-22","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":41606,"accession_number":"0001828316-26-000047","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release announcing preliminary third-quarter 2026 financial results for Pharming Group N.V., disclosing total revenues of approximately US$117.6 million (21% year-over-year growth) and operating expenses of US$74.6 million, along with tightened full-year 2026 revenue guidance. The disclosure explicitly states \"Pharming Group announces third quarter 2026 revenues above market expectations\" and provides preliminary unaudited revenue and select financial information for the three months ended September 30, 2026, which is the hallmark of an earnings release.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-22T11:07:56.774571+00:00","company_name":"Pharming Group N.V.","ticker":"PHAR","filing_date":"2026-10-22"}]}